CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
41.63
-0.53 (-1.26%)
Jan 23, 2026, 4:00 PM EST - Market closed
CONMED Stock Forecast
Stock Price Forecast
The 6 analysts that cover CONMED stock have a consensus rating of "Hold" and an average price target of $53.67, which forecasts a 28.92% increase in the stock price over the next year. The lowest target is $47 and the highest is $61.
Price Target: $53.67 (+28.92%)
Analyst Consensus: Hold
* Price targets were last updated on Dec 8, 2025.
Analyst Ratings
The average analyst rating for CONMED stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 4 | 4 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Hold Maintains $65 → $52 | Hold | Maintains | $65 → $52 | +24.91% | Dec 8, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $58 → $52 | Hold | Maintains | $58 → $52 | +24.91% | Nov 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $68 → $55 | Buy | Maintains | $68 → $55 | +32.12% | Nov 6, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $57 → $47 | Hold | Maintains | $57 → $47 | +12.90% | Nov 6, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $80 → $68 | Buy | Maintains | $80 → $68 | +63.34% | Jul 31, 2025 |
Financial Forecast
Revenue This Year
1.40B
from 1.31B
Increased by 6.81%
Revenue Next Year
1.41B
from 1.40B
Increased by 0.64%
EPS This Year
4.59
from 4.25
Increased by 8.04%
EPS Next Year
4.59
from 4.59
Decreased by -0.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.4B | 1.5B | ||
| Avg | 1.4B | 1.4B | ||
| Low | 1.3B | 1.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 10.1% | 8.7% | ||
| Avg | 6.8% | 0.6% | ||
| Low | 2.5% | -6.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 4.74 | 5.20 | ||
| Avg | 4.59 | 4.59 | ||
| Low | 4.39 | 4.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 11.4% | 13.2% | ||
| Avg | 8.0% | -0.1% | ||
| Low | 3.3% | -9.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.